🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
On the basis of Xiashi skin surgery clinical experience, this project adopt...
Status
Unknown
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02517957
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
This study is to assess the onset of action of fixed drug combination of az...
Status
Completed
Location
Inflamax Research
Start Date
2017-01-07
Trial ID
NCT03004131
This is a Phase 3, randomized, parallel-group, multicenter, double-dummy, d...
Status
Completed
Location
Multiple Locations
Start Date
2006-03-01
Trial ID
NCT00319995
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of short rag...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT02478398
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
This is a single-center, randomized, double-masked, parallel study. In this...
Status
Completed
Location
Andover Eye Associates
Start Date
2021-12-14
Trial ID
NCT05265910
Treatments Being Tested
The primary objective of the study was to characterize the difference in pr...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00449072
Treatments Being Tested
The research question for the current study is: Is loratadine more effectiv...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2024-11-28
Trial ID
NCT05421416
Treatments Being Tested